Back to Search
MINDY WANG, MD
MD
Diagnostic Radiology Physician
NPI: 1821593716IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
U5260(TX)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 2018
Research & Publications (20)
CR represents an early index of potential long survival in multiple myeloma.
PMID 19633690·Bone Marrow Transplant·2010
8-other
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
PMID 19225534·Leukemia·2009
8-other
Intracellular delivery of proteins into mouse Müller glia cells in vitro and in vivo using Pep-1 transfection reagent.
PMID 19056421·J Neurosci Methods·2009
7-preclinical
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
PMID 18973182·Cancer·2008
3-trial
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma.
PMID 18937267·Cancer·2008
8-other
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
PMID 18799726·Blood·2008
4-observational
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
PMID 18381957·Clin Cancer Res·2008
7-preclinical
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.
PMID 17898787·Leukemia·2008
7-preclinical
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.
PMID 17558699·Hematology·2007
3-trial
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
PMID 17317853·Blood·2007
7-preclinical
Use of bortezomib in B-cell non-Hodgkin's lymphoma.
PMID 16831071·Expert Rev Anticancer Ther·2006
6-review
Asymmetrical vertical phorias in normal subjects: the influence of unbalanced illumination.
PMID 16251141·Strabismus·2005
8-other
Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma.
PMID 16215459·J Neuropathol Exp Neurol·2005
5-case
Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.
PMID 15981221·Am J Hematol·2005
3-trial
Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina.
PMID 12687700·J Comp Neurol·2003
7-preclinical
Testicular lymphoma: a mysterious link between the testis and the brain.
PMID 12521395·Clin Lymphoma·2002
8-other
Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.
PMID 11474279·Am J Clin Oncol·2001
5-case
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
PMID 18413598·Proc Natl Acad Sci U S A·2008
7-preclinical
Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone.
PMID 15367397·Am J Physiol Endocrinol Metab·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1821593716
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile